# Hypertension in Pregnancy

> Hypertension in pregnancy is defined as:<br/>- **Systolic BP ≥ 140 mmHg** and/or<br/>- **Diastolic BP ≥ 90 mmHg**<br/>on **two occasions** at least **4 hours apart** after **20 weeks gestation** in a previously normotensive woman.

## Classification of Hypertension in Pregnancy

1. **Chronic Hypertension**

   - Present before pregnancy or before 20 weeks
   - Persists > 12 weeks postpartum

2. **Gestational Hypertension**

   - New onset BP ≥ 140/90 after 20 weeks
   - No proteinuria or systemic features
   - Resolves by 12 weeks postpartum

3. **Pre-eclampsia**

   - BP ≥ 140/90 after 20 weeks + **Proteinuria** ≥ 300 mg/day
   - OR end-organ dysfunction (without proteinuria)

4. **Severe Pre-eclampsia**

   - BP ≥ 160/110
   - With proteinuria or systemic features (e.g. visual symptoms, thrombocytopenia, liver dysfunction, renal impairment)

5. **Eclampsia**

   - Pre-eclampsia + **Generalized tonic-clonic seizures**
   - Not due to other neurological causes

6. **Superimposed Pre-eclampsia on Chronic Hypertension**

## Risk Factors

### Maternal Risk Factors

- **Primigravida**
- Extremes of maternal age (< 18 or > 35)
- Family or personal history of pre-eclampsia
- Multiple pregnancy
- Obesity (BMI > 30)
- Chronic hypertension
- Chronic kidney disease
- Autoimmune disease
- Thrombophilias
- Low socioeconomic status
- Vitamin D deficiency

### Fetal Risk Factors

- Male fetus
- Fetal growth restriction (FGR)
- Genetic factors
- Placental abnormalities

## Pathophysiology of Pre-eclampsia → Eclampsia

- **Abnormal placentation** → Abnormal trophoblastic invasion → Small spiral arteries → Uteroplacental ischemia → Release of inflammatory cytokines → Systemic endothelial dysfunction
- Vasospasm & ↑ vascular permeability → Less blood flow to organs (**Multiorgan dysfunction**)
- Less blood flow to kidney → ↓ GFR → **Proteinuria**
- Less blood flow to brain → Cerebral edema, vasospasm → Seizures → **Eclampsia**

## Clinical Features

### History

- Headache, visual disturbances (blurring, scotoma)
- Epigastric/right upper quadrant pain
- Reduced urine output
- Edema (hands, face, generalized)
- Dyspnea (pulmonary edema)
- Convulsions (eclampsia)

### Examination

- BP monitoring
- Reflexes (hyperreflexia in pre-eclampsia)
- Clonus (≥ 3 beats → CNS irritability)
- Fundus for papilledema
- Lung exam: basal crepitations (pulmonary edema)
- Fetal growth and well-being

## Investigations

### For Diagnosis

- BP measurements
- **Urine Protein:**

  - Dipstick ≥ +2
  - 24-hour urine protein ≥ 300 mg/day
  - Spot protein/creatinine ratio > 0.3

### For Severity & Complications

- CBC – ↓ Platelets
- LFT – ↑ AST, ALT (HELLP syndrome)
- RFT – ↑ creatinine, urea
- Uric acid – may be elevated
- Coagulation profile (DIC risk)
- LDH – ↑ in haemolysis
- Fundoscopy
- Chest X-ray (pulmonary edema)

### Fetal Surveillance

- Ultrasound – fetal growth, AFI, Doppler
- CTG – fetal well-being

## Complications

### Maternal

- Eclampsia
- HELLP syndrome
- Pulmonary edema
- DIC
- Placental abruption
- Renal failure
- Liver rupture
- Death

### Fetal

- IUGR
- Prematurity
- Placental abruption
- Intrauterine death
- Low birth weight

## Management

import { Tabs } from "nextra/components";

<Tabs items={['Eclampsia', 'Pre-eclampsia']}>
<Tabs.Tab>

### 1. Resuscitation (ABCDEF Approach)

- **A – Airway**

  - Clear airway, place woman in **left lateral** position
  - Suction to prevent aspiration

- **B – Breathing**

  - Oxygen via face mask (10–15 L/min)
  - Monitor SpO₂ continuously

- **C – Circulation**

  - Insert two large-bore IV cannulas
  - Start `isotonic` IV fluids (e.g. 0.9% saline) → avoid fluid overload
  - Avoid hypotension

- **D – Disability**

  - Assess GCS
  - Protect from injury during seizure (padding, rails)

- **E – Exposure**

  - Remove objects that can be harmful to the patients during seizure

- **F – Fetus**

  - Continuous CTG if viable fetus

### 2. Control of Blood Pressure

- Indicated if **BP ≥160/110 mmHg**
- Target BP: 140–150/90–100 mmHg

| Drug          | Route | Dose                          | Side Effects                    | Contraindications         |
| ------------- | ----- | ----------------------------- | ------------------------------- | ------------------------- |
| `Labetalol`   | IV/PO | 20 mg IV bolus, 100–200 mg PO | Bradycardia, bronchospasm       | Asthma, heart block       |
| `Hydralazine` | IV/IM | 5–10 mg IV q20min             | Reflex tachycardia, hypotension | CAD, valvular disease     |
| `Nifedipine`  | PO    | 10–20 mg PO                   | Headache, flushing              | Hypotension, MgSO₄ use    |
| `Methyldopa`  | PO    | 250–500 mg TID                | Sedation, liver issues          | Liver disease, depression |

### 3. Control of Seizures

- `Magnesium Sulphate` is drug of choice

  - **Loading dose**: 4 g IV over 10–20 mins
  - **Maintenance**: 1 g/hour IV for 24 hours after last seizure or delivery
  - Monitor for toxicity

- If seizures recur despite MgSO₄:

  - Repeat 2 g IV bolus over 5–10 mins
  - If still uncontrolled: consider `diazepam` or `thiopental` in ICU setting

- **Antidote for toxicity**: `10% Calcium gluconate` IV 10 mL over 10 mins
- Monitor:

  - Patellar reflex (absent = early toxicity)
  - Respiratory rate (>12/min)
  - Urine output (>25–30 mL/hr)

### 4. Control of Other Complications

- **Pulmonary edema** → restrict fluids, give `furosemide` (no max limit), `GTN drip`
- **Renal failure** → monitor urea/creatinine, input/output chart
- **DIC/HELLP syndrome** → monitor platelets, LFTs, LDH, coagulation profile
- **Stroke or ICH** → neuroimaging if prolonged unconsciousness or focal signs

### 5. Monitoring (Mother & Baby)

#### Mother:

- BP every 15–30 mins
- Pulse, RR, SpO₂, reflexes hourly
- Urine output (catheter)
- Blood tests: CBC, LFT, RFT, coagulation
- Watch for MgSO₄ toxicity, pulmonary edema, oliguria

#### Fetus:

- Continuous **CTG** monitoring if fetus viable
- Ultrasound if needed (growth, liquor, Dopplers)

### 6. Delivery of the Baby

- **Timing**: After mother stabilized, ideally within 12 hours
- **Mode**:

  - Vaginal preferred if labour progressing and mother stable
  - Caesarean if obstetric indication (e.g. fetal distress, failed induction)

- **Labour Management**:

  - Avoid `ergometrine` (can raise BP)
  - Use `oxytocin` for uterotonic effect
  - Epidural contraindicated if low platelets

### 7. Postpartum Care

- Continue `Magnesium Sulphate for 24 hours` after last seizure/delivery
- Continue `antihypertensives`
- Monitor vitals, reflexes, urine output
- Restrict fluid
- Counsel on recurrence risk and long-term cardiovascular risk
- Follow-up at 6 weeks postpartum (BP, renal function)

</Tabs.Tab>

<Tabs.Tab>

## Goals of Management

- Prevent progression to eclampsia
- Control BP
- Prevent maternal & fetal complications
- Deliver at optimal time

## A. Antenatal Management Based on Severity

<Tabs items={['Non-Severe', 'Severe']}>

<Tabs.Tab>

### Non-Severe Pre-eclampsia

- **BP 140–159/90–109 mmHg**, no severe features

#### Antihypertensives

| Drug          | Route | Dose                          | Side Effects                    | Contraindications         |
| ------------- | ----- | ----------------------------- | ------------------------------- | ------------------------- |
| `Labetalol`   | IV/PO | 20 mg IV bolus, 100–200 mg PO | Bradycardia, bronchospasm       | Asthma, heart block       |
| `Hydralazine` | IV/IM | 5–10 mg IV q20min             | Reflex tachycardia, hypotension | CAD, valvular disease     |
| `Nifedipine`  | PO    | 10–20 mg PO                   | Headache, flushing              | Hypotension, MgSO₄ use    |
| `Methyldopa`  | PO    | 250–500 mg TID                | Sedation, liver issues          | Liver disease, depression |

- **Monitor**:

  - BP: at least twice a week
  - Bloods: twice weekly or as needed
  - Fetal well-being: weekly CTG + serial scans

#### Corticosteroids (if \<34 weeks):

> To enhance fetal lung maturity in preterm (\<34 weeks) gestation:

- `Betamethasone` 12 mg IM every 24 hr × 2 doses **OR**
- `Dexamethasone` 6 mg IM every 12 hr × 4 doses

#### Delivery

- **At 37 weeks** or earlier if clinical deterioration

</Tabs.Tab>

<Tabs.Tab>

### Severe Pre-eclampsia

- **BP ≥160/110 mmHg** or
- Evidence of organ dysfunction (CNS, liver, kidney, platelets) or fetal compromise

#### Immediate Management (admit to tertiary care):

- Bed rest (not strict), continuous monitoring
- Start `antihypertensives` and `magnesium sulphate` (for seizure prophylaxis)

#### Antihypertensives:

| Drug          | Route | Dose                          | Side Effects                    | Contraindications         |
| ------------- | ----- | ----------------------------- | ------------------------------- | ------------------------- |
| `Labetalol`   | IV/PO | 20 mg IV bolus, 100–200 mg PO | Bradycardia, bronchospasm       | Asthma, heart block       |
| `Hydralazine` | IV/IM | 5–10 mg IV q20min             | Reflex tachycardia, hypotension | CAD, valvular disease     |
| `Nifedipine`  | PO    | 10–20 mg PO                   | Headache, flushing              | Hypotension, MgSO₄ use    |
| `Methyldopa`  | PO    | 250–500 mg TID                | Sedation, liver issues          | Liver disease, depression |

#### Seizure Prophylaxis:

- `Magnesium Sulphate (MgSO₄)`:

  - **Loading**: 4 g IV over 10–20 mins
  - **Maintenance**: 1 g/hour IV infusion for 24 hours
  - Monitor toxicity
  - **Antidote for toxicity**: `10% Calcium gluconate` IV 10 mL over 10 mins

- Monitor:

  - Patellar reflex (absent = early toxicity)
  - Respiratory rate (>12/min)
  - Urine output (>25–30 mL/hr)

#### Corticosteroids (if \<34 weeks):

> To enhance fetal lung maturity in preterm (\<34 weeks) gestation:

- `Betamethasone` 12 mg IM every 24 hr × 2 doses **OR**
- `Dexamethasone` 6 mg IM every 12 hr × 4 doses

#### Fluid Management:

- Restrict to 80–100 mL/hour unless bleeding
- Avoid pulmonary edema

</Tabs.Tab>

</Tabs>

## B. Monitoring

### Mother:

- BP: Hourly if severe, otherwise 4–6 hourly
- Urine output: Catheter, chart input/output
- Daily labs: CBC, LFT, RFT, coagulation profile
- Monitor for symptoms: headache, visual change, RUQ pain

### Fetus:

- Daily CTG if viable
- Ultrasound every 1–2 weeks for growth and Doppler

## C. Timing of Delivery

- **\<34 weeks**: Conservative if stable
- **34–36+6 weeks**: Individualised based on maternal/fetal condition
- **≥37 weeks**: Plan delivery
- **Immediate delivery** if:

  - Uncontrolled hypertension
  - Eclampsia or impending eclampsia
  - DIC/HELLP
  - Non-reassuring fetal status
  - Pulmonary edema or organ failure

## D. Intrapartum

- Vaginal preferred if possible
- Avoid ergometrine (can raise BP) in 3rd stage
- Use oxytocin for uterine contraction

## E. Postpartum Care

- Continue antihypertensives (e.g., labetalol, nifedipine)
- Monitor BP for 72 hours (may worsen)
- Monitor for late eclampsia
- Follow-up at 6 weeks: BP, renal function, proteinuria
- Long-term risk: chronic hypertension, cardiovascular disease

</Tabs.Tab>

</Tabs>
